18F-FDG PET/CT for the assessment of myocardial sarcoidosis. - Wikidata - awgldk - TriplyDB

18F-FDG PET/CT for the assessment of myocardial sarcoidosis.

18F-FDG PET/CT for the assessment of myocardial sarcoidosis.

http://www.wikidata.org/entity/Q33564610

about

Incremental value of PET and MRI in the evaluation of cardiovascular abnormalities Cardiac sarcoidosis-state of the art review Sarcoidosis and the heart: A review of the literature.Clinical Utility and Future Applications of PET/CT and PET/CMR in Cardiology.Cardiac sarcoidosis: case report, workup, and review of the literature.Sarcoidosis misdiagnosed as malignant tumors: a case report.Seasonal Temperature Changes Do Not Affect Cardiac Glucose Metabolism.Multimodality Imaging in Cardiac Sarcoidosis: Is There a Winner?Effect of Bayesian-penalized likelihood reconstruction on [13N]-NH3 rest perfusion quantification.Clinical applications of radionuclide imaging in the evaluation and management of patients with congenital heart disease.Cardiac sarcoidosis: diagnosis and management.Advances in radionuclide imaging of cardiac sarcoidosis.Multimodality imaging in restrictive cardiomyopathies: an EACVI expert consensus document: In collaboration with the 'Working Group on myocardial and pericardial diseases' of the European Society of Cardiology Endorsed by the Indian Academy of Echoc Nuclear Cardiology: Are We Using the Right Protocols and Tracers the Right Way?T wave amplitude in lead aVR as a novel diagnostic marker for cardiac sarcoidosis.Status of cardiovascular PET radiation exposure and strategies for reduction: An Information Statement from the Cardiovascular PET Task Force.Role of Cardiac PET in Clinical Practice.Search for key manifestations to predict inflammation on cardiac PET in suspected cardiac sarcoidosis population.Feasibility of FDG-PET in myocarditis: Comparison to CMR using integrated PET/MRI.ASNC imaging guidelines/SNMMI procedure standard for positron emission tomography (PET) nuclear cardiology procedures

P2860

Q26746074-BB6F7D02-AE9E-480D-8B23-88BBC9D8511A Q26765213-2D849304-FFF2-4A33-9A3F-2E9B32DA729A Q26775782-E1BD0D9A-4E40-4993-8462-DFD2645765C7 Q28073135-B6FDE51D-11C5-4D60-AECB-3857DB3C21AE Q30434303-6D43B96F-A723-435A-B4B2-E95781BC080B Q36366066-CDF54B4E-777B-4FFC-8112-D3CEE9D19F5E Q36453564-F1B298E0-C42E-4137-BD3E-3984ABC3B69C Q36728670-4C592516-2D7E-47ED-9F49-1AF6186E5753 Q37375799-0340E96C-3A1F-4C47-A6EE-B1EB4AE353C4 Q38541049-D14EE273-4B22-4CEC-920B-A171E4ACCEBF Q38541252-10A15923-15B2-409A-A16E-B3422E335314 Q38574702-37C303FA-292E-4FA3-B87D-FBB4512A5A07 Q38782767-22B8B326-DBEF-4E9D-9636-F3F62BE0A663 Q39263812-0CE4B364-6BD4-45DD-B59C-151E5D26C177 Q39552844-62C593F8-479E-4A80-8195-A5C2CB1B7D96 Q40209620-4561D01B-9C4E-4C44-9180-51AA9D7004F6 Q47628378-EA6D2FF6-03DA-4E19-B02B-7E6A18C9CFFC Q54150157-816B2FB6-AFC4-4C49-9C28-3089974B2895 Q54418301-76910413-E41A-4DD7-A468-25B182E4ACF6 Q57621434-6DCBD13C-03B9-4039-8876-DD3FD78FC893

P2860

18F-FDG PET/CT for the assessment of myocardial sarcoidosis.

http://www.wikidata.org/entity/Q33564610

description

2013 nî lūn-bûn

@nan

2013 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

2013 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

name

18F-FDG PET/CT for the assessment of myocardial sarcoidosis.

@ast

18F-FDG PET/CT for the assessment of myocardial sarcoidosis.

@en

18F-FDG PET/CT for the assessment of myocardial sarcoidosis.

@nl

type

label

18F-FDG PET/CT for the assessment of myocardial sarcoidosis.

@ast

18F-FDG PET/CT for the assessment of myocardial sarcoidosis.

@en

18F-FDG PET/CT for the assessment of myocardial sarcoidosis.

@nl

prefLabel

18F-FDG PET/CT for the assessment of myocardial sarcoidosis.

@ast

18F-FDG PET/CT for the assessment of myocardial sarcoidosis.

@en

18F-FDG PET/CT for the assessment of myocardial sarcoidosis.

@nl

P1433

Q33564610-0E4743C9-F976-4198-9BDE-6656052F4D1B

P1476

Q33564610-8F65C322-8D08-4AB5-A56A-8CF65AFA1C4E

P2093

Q33564610-2562B0F6-166A-4590-BB06-76E735C508B6

Q33564610-E4D18981-46C7-4AA7-882C-862D7FB710CA

P2860

Q33564610-0C2F6159-321A-48F6-9158-6283C1A10A79

Q33564610-109EC38A-7122-4D84-ADE9-7D08A231DF3C

Q33564610-194A7750-CE6E-4733-BF01-168FE06E2C73

Q33564610-1FDB5036-C9C6-4842-AA63-5F981AEDFFF6

Q33564610-2A95C815-A4E3-43A6-B4EC-7E3111101C5B

Q33564610-35882772-EE9F-415F-B61A-F6ECDF889417

Q33564610-3985B784-B89D-47A1-B746-B8B863D21A96

Q33564610-4C62FB00-AC21-4FCF-A803-EA9041B9C75B

Q33564610-507317EC-9446-4ACE-B6A6-D6391E03C1ED

Q33564610-51483E44-2FF7-48A6-8303-FFDD2C683A7B

P2888

Q33564610-5A950350-C8C0-4466-85CC-110F8F41711E

P304

Q33564610-17F8982C-A7A8-410B-B310-ACF5FBF22C15

P31

Q33564610-AEBEDC84-4BD3-4DB4-94E0-27F3B2FEEE46

P356

Q33564610-E7512B15-C68B-433F-9A62-E57BE4177E34

P433

Q33564610-DEC6EBBC-5379-46D8-A291-5FA0325E252E

P478

Q33564610-E60775B9-7901-4B0E-8074-EDB4BE7B7731

P50

Q33564610-A187A16C-6C1A-40EC-99F9-4AE1A5A4A8DB

P577

Q33564610-1C35FF52-A03B-49CD-84F3-427887638CF8

P6179

Q33564610-F8D7D495-5897-42FD-BFB5-E8CF0790DA44

P698

Q33564610-FE5D567B-8975-449D-9656-9AAD3C45E385

P932

Q33564610-10CADC02-2B7A-4C3C-840A-3883CD8E02A7

P356

S11886-013-0370-6

P1433

Current cardiology reports

P1476

18F-FDG PET/CT for the assessment of myocardial sarcoidosis.

@en

P2093

Allison R Schulman

http://www.w3.org/2001/XMLSchema#string

Sharmila Dorbala

http://www.w3.org/2001/XMLSchema#string

P2860

Cardiac sarcoidosis.

The use of 18F-FDG PET in the diagnosis of cardiac sarcoidosis: a systematic review and metaanalysis including the Ontario experience

Cardiac involvement in patients with sarcoidosis: diagnostic and prognostic value of outpatient testing.

Cardiac sarcoidosis: applications of imaging in diagnosis and directing treatment.

Sarcoid heart disease: clinical course and treatment.

Cardiac involvement in sarcoidosis.

The work-up and management of patients with apparent or subclinical cardiac sarcoidosis: with emphasis on the associated heart rhythm abnormalities.

Cardiac manifestations of sarcoidosis and therapeutic options.

Cardiac positron emission tomography enhances prognostic assessments of patients with suspected cardiac sarcoidosis.

Imaging of inflammation by PET, conventional scintigraphy, and other imaging techniques.

P2888

s11886-013-0370-6

P304

352

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S11886-013-0370-6

http://www.w3.org/2001/XMLSchema#string

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

15

http://www.w3.org/2001/XMLSchema#string

P50

P577

2013-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1007466609

http://www.w3.org/2001/XMLSchema#string

P698

23544184

http://www.w3.org/2001/XMLSchema#string

P932

4009625

http://www.w3.org/2001/XMLSchema#string